At meeting held on 17 June 2018 the board of Parmax Pharma at its meeting held on 17 June 2018 has approved the following:
- Appointment of Ami R. Shah as Additional Independent Director.
- The expansion of plant for manufacturing of API products under Goods Manufacturing Practices. – Business Standard